文献速递消化内镜消化道肿瘤与早癌

基于人群的研究:筛查或监测结肠镜检查的胃肠道和非胃肠道并发症发生率低

Low Rates of Gastrointestinal and Non-Gastrointestinal Complications for Screening or Surveillance Colonoscopies in a Population-Based Study.
PubMed 文献 · Gastroenterology · 2017-10-12

S-colo后严重胃肠道并发症发生率低但有临床意义,心肌梗死、卒中和严重肺部事件发生率不高于低风险对照操作。

要点

  • S-colo后下消化道出血、穿孔、心肌梗死、缺血性卒中的发生率分别为每万人5.3、2.9、2.5、4.7例(未活检或介入),活检或介入后分别为36.4、6.3、4.2、9.1例。
  • S-colo后严重胃肠道并发症的调整比值比范围为2.18(95%CI 2.02-2.36)至5.13(95%CI 4.81-5.47),高于对照操作。
  • 活检或介入、合并症、黑人种族、低收入、公共保险和NS-colo与结肠镜后不良事件相关。

核心结论

  • S-colo后严重胃肠道不良事件发生率低但有临床意义,心肌梗死、卒中和严重肺部事件发生率不高于低风险对照操作后。
  • S-colo后心肌梗死发生率与一般人群相似,但卒中发生率高于一般人群报告的发生率。

研究设计与样本

  • 基于人群的研究,利用加州医院所有和非医院所有的门诊手术中心、急诊和住院数据库,时间范围为2005年1月1日至2011年12月31日。
  • 通过患者层面链接至加州急诊和住院数据库,识别30天内发生的不良事件及相关因素。

主要发现

  • S-colo后未活检或介入者下消化道出血、穿孔、心肌梗死、缺血性卒中每万人发生数分别为5.3(95%CI 4.8-5.9)、2.9(95%CI 2.5-3.3)、2.5(95%CI 2.1-2.9)、4.7(95%CI 4.1-5.2);活检或介入者分别为36.4(95%CI 35.1-37.6)、6.3(95%CI 5.8-6.8)、4.2(95%CI 3.8-4.7)、9.1(95%CI 8.5-9.7)。
  • 心律失常发生率更高。
  • NS-colo后事件发生率显著更高。
  • 多数严重并发症导致住院,多数胃肠道并发症发生在结肠镜检查后14天内。
  • S-colo对比对照操作,严重胃肠道并发症、心肌梗死、缺血性卒中、严重肺部事件的调整比值比范围分别为2.18(95%CI 2.02-2.36)至5.13(95%CI 4.81-5.47)、0.67(95%CI 0.56-0.81)至0.99(95%CI 0.83-1.19)、0.66(95%CI 0.59-0.75)至1.13(95%CI 0.99-1.29)、0.64(95%CI 0.61-0.68)至1.05(95%CI 0.98-1.11)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The full spectrum of serious non-gastrointestinal post-colonoscopy complications has not been well characterized. We analyzed rates of and factors associated with adverse post-colonoscopy gastrointestinal (GI) and non-gastrointestinal events (cardiovascular, pulmonary, or infectious) attributable to screening or surveillance colonoscopy (S-colo) and non-screening or non-surveillance colonoscopy (NS-colo). METHODS: We performed a population-based study of colonoscopy complications using databases from California hospital-owned and nonhospital-owned ambulatory facilities, emergency departments, and hospitals from January 1, 2005 through December 31, 2011. We identified patients who underwent S-colo (1.58 million), NS-colo (1.22 million), or low-risk comparator procedures (joint injection, aspiration, lithotripsy; arthroscopy, carpal tunnel; or cataract; 2.02 million) in California's Ambulatory Services Databases. We identified patients who developed adverse events within 30 days, and factors associated with these events, through patient-level linkage to California's Emergency Department and Inpatient Databases. RESULTS: After S-colo, the numbers of lower GI bleeding, perforation, myocardial infarction, and ischemic stroke per 10,000-persons were 5.3 (95% confidence interval [CI], 4.8-5.9), 2.9 (95% CI, 2.5-3.3), 2.5 (95% CI, 2.1-2.9), and 4.7 (95% CI, 4.1-5.2) without biopsy or intervention; with biopsy or intervention, numbers per 10,000-persons were 36.4 (95% CI, 35.1-37.6), 6.3 (95% CI, 5.8-6.8), 4.2 (95% CI, 3.8-4.7), and 9.1 (95% CI, 8.5-9.7). Rates of dysrhythmia were higher. After NS-colo, event rates were substantially higher. Most serious complications led to hospitalization, and most GI complications occurred within 14 days of colonoscopy. Ranges of adjusted odds ratios for serious GI complications, myocardial infarction, ischemic stroke, and serious pulmonary events after S-colo vs comparator procedures were 2.18 (95% CI, 2.02-2.36) to 5.13 (95% CI, 4.81-5.47), 0.67 (95% CI, 0.56-0.81) to 0.99 (95% CI, 0.83-1.19), 0.66 (95% CI, 0.59-0.75) to 1.13 (95% CI, 0.99-1.29), and 0.64 (95% CI, 0.61-0.68) to 1.05 (95% CI, 0.98-1.11). Biopsy or intervention, comorbidity, black race, low income, public insurance, and NS-colo were associated with post-colonoscopy adverse events. CONCLUSIONS: In a population-based study in California, we found that following S-colo, rates of serious GI adverse events were low but clinically relevant, and that rates of myocardial infarction, stroke, and serious pulmonary events were no higher than after low-risk comparator procedures. Rates of myocardial infarction are similar to, but rates of stroke are higher than, those reported for the general population.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Wang L, Mannalithara A, Singh G, et al. Low Rates of Gastrointestinal and Non-Gastrointestinal Complications for Screening or Surveillance Colonoscopies in a Population-Based Study. Gastroenterology. 2017. PMID: 29031502. doi:10.1053/j.gastro.2017.10.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。